Epizyme, Inc. Insider Trading for February 2014
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Epizyme, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Epizyme, Inc. for February 2014.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 12 2014 | EPZM | Epizyme, Inc. | KPCB XIII Associates, LLC | 10% Owner | Sell | S | 27.64 | 388,584 | 10,740,967 | 3,838,167 | 4.2 M to 3.8 M (-9.19 %) |
| Feb 12 2014 | EPZM | Epizyme, Inc. | Hedrick Eric | Chief Medical Offic ... | Option Exercise | M | 2.19 | 13,500 | 29,565 | 286,500 | |
| Feb 12 2014 | EPZM | Epizyme, Inc. | Hedrick Eric | Chief Medical Offic ... | Sell | S | 29.25 | 13,500 | 394,875 | 0 | 13.5 K to 0 (-100.00 %) |
| Feb 12 2014 | EPZM | Epizyme, Inc. | Hedrick Eric | Chief Medical Offic ... | Buy | M | 2.19 | 13,500 | 29,565 | 13,500 | 0 to 13.5 K |
| Feb 12 2014 | EPZM | Epizyme, Inc. | Copeland Robert A | EVP and CSO | Sell | S | 29.25 | 19,179 | 560,986 | 24,911 | 44.1 K to 24.9 K (-43.50 %) |
| Feb 12 2014 | EPZM | Epizyme, Inc. | Rhodes Jason P | President, CFO and ... | Option Exercise | M | 0.51 | 20,000 | 10,200 | 292,459 | |
| Feb 12 2014 | EPZM | Epizyme, Inc. | Rhodes Jason P | President, CFO and ... | Option Exercise | M | 3.54 | 50,000 | 177,000 | 260,833 | |
| Feb 12 2014 | EPZM | Epizyme, Inc. | Rhodes Jason P | President, CFO and ... | Sell | S | 29.25 | 50,000 | 1,462,500 | 24,000 | 74 K to 24 K (-67.57 %) |
| Feb 12 2014 | EPZM | Epizyme, Inc. | Rhodes Jason P | President, CFO and ... | Buy | M | 0.51 | 20,000 | 10,200 | 74,000 | 54 K to 74 K (+37.04 %) |
| Feb 12 2014 | EPZM | Epizyme, Inc. | Rhodes Jason P | President, CFO and ... | Buy | M | 3.54 | 50,000 | 177,000 | 54,000 | 4 K to 54 K (+1,250.00 %) |
| Feb 12 2014 | EPZM | Epizyme, Inc. | GOLDFISCHER CARL | Director | Sell | S | 29.25 | 8,727 | 255,265 | 3,192,062 | 3.2 M to 3.2 M (-0.27 %) |
| Feb 12 2014 | EPZM | Epizyme, Inc. | GOLDFISCHER CARL | Director | Sell | S | 29.25 | 457,940 | 13,394,745 | 3,200,789 | 3.7 M to 3.2 M (-12.52 %) |
| Feb 12 2014 | EPZM | Epizyme, Inc. | Gould Robert J | CEO | Option Exercise | M | 0.51 | 60,000 | 30,600 | 807,223 | |
| Feb 12 2014 | EPZM | Epizyme, Inc. | Gould Robert J | CEO | Sell | S | 29.25 | 60,000 | 1,755,000 | 0 | 60 K to 0 (-100.00 %) |
| Feb 12 2014 | EPZM | Epizyme, Inc. | Gould Robert J | CEO | Buy | M | 0.51 | 60,000 | 30,600 | 60,000 | 0 to 60 K |
| Feb 12 2014 | EPZM | Epizyme, Inc. | BAY CITY CAPITAL LLC | 10% Owner | Sell | S | 29.25 | 8,727 | 255,265 | 3,192,062 | 3.2 M to 3.2 M (-0.27 %) |
| Feb 12 2014 | EPZM | Epizyme, Inc. | BAY CITY CAPITAL LLC | 10% Owner | Sell | S | 29.25 | 457,940 | 13,394,745 | 3,200,789 | 3.7 M to 3.2 M (-12.52 %) |
| Feb 12 2014 | EPZM | Epizyme, Inc. | SEIDENBERG BETH C | Director | Sell | S | 27.64 | 388,584 | 10,740,967 | 3,838,167 | 4.2 M to 3.8 M (-9.19 %) |
| Feb 11 2014 | EPZM | Epizyme, Inc. | Celgene European Investment Co ... | 10% Owner | Buy | P | 29.25 | 340,000 | 9,945,000 | 3,674,640 | 3.3 M to 3.7 M (+10.20 %) |
| Feb 11 2014 | EPZM | Epizyme, Inc. | MPM BioVentures IV QP LP | 10% Owner | Sell | S | 29.25 | 466,666 | 13,649,981 | 2,413,819 | 2.9 M to 2.4 M (-16.20 %) |
| Feb 11 2014 | EPZM | Epizyme, Inc. | EVNIN LUKE | 10% Owner | Sell | S | 29.25 | 466,666 | 13,649,981 | 2,413,819 | 2.9 M to 2.4 M (-16.20 %) |